Accenture (NYSE: ACN) director now holds 9,627 shares

Rhea-AI Filing Summary

Accenture plc (ACN) director Arun Sarin reported an acquisition of 13 Class A ordinary shares on 2026-08-14 through a grant of Restricted Share Units (RSUs). The RSUs were issued under anti-dilution provisions to reflect Accenture's payment of a cash dividend. Following this grant, Sarin directly holds 9,627 shares of Accenture.

Insider Trade Summary

Net Buyer: 13 shares

Net Buy 1 txn

Insider Sarin Arun

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares F1	13	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 9,627 shares (Direct)

Footnotes (1)

1. F1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Key Figures

Shares granted: 13 Class A ordinary shares Grant price per share: $0.0000 per share Shares owned after transaction: 9,627 Class A ordinary shares

3 metrics

Shares granted 13 Class A ordinary shares Grant of RSUs pursuant to anti-dilution provisions on 2026-08-14

Grant price per share $0.0000 per share Reported transaction price for the 13-share RSU grant

Shares owned after transaction 9,627 Class A ordinary shares Direct ownership by Arun Sarin following the RSU grant

Key Terms

Restricted Share Units (RSUs), anti-dilution provisions, cash dividend

3 terms

Restricted Share Units (RSUs) financial

"Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions"

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

anti-dilution provisions financial

"pursuant to the anti-dilution provisions of previously granted RSU awards"

Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.

cash dividend financial

"to reflect Accenture plc's payment of a cash dividend"

A cash dividend is a payment made by a company to its shareholders directly in money, usually on a regular schedule. It is a way for investors to receive a portion of the company's profits, similar to earning interest or a bonus for holding the company's stock. Cash dividends provide income to shareholders and can indicate the company's financial health and stability.

FAQ

What did Accenture (ACN) director Arun Sarin report in this Form 4 filing?

Arun Sarin reported an acquisition of 13 Class A ordinary shares of Accenture plc via a Restricted Share Unit (RSU) grant. This grant arose from anti-dilution provisions tied to Accenture's payment of a cash dividend.

How many Accenture (ACN) shares does Arun Sarin hold after this transaction?

After the reported transaction, Arun Sarin directly holds 9,627 Class A ordinary shares of Accenture plc. This total reflects the addition of 13 shares granted as RSUs under the anti-dilution provisions related to a cash dividend.

What is the nature of the 13-share award reported for Accenture (ACN)?

The 13-share award is a grant of Restricted Share Units (RSUs) issued under anti-dilution provisions. It was made to adjust previously granted RSU awards to account for Accenture plc's payment of a cash dividend to shareholders.

Did Arun Sarin buy or sell Accenture (ACN) shares on the open market?

No open-market trade is reported; the filing shows a grant/award acquisition of 13 shares at a price of $0.00 per share. These shares were issued as RSUs under anti-dilution provisions, not purchased or sold on an exchange.

Was this Accenture (ACN) insider transaction made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not checked, so this transaction is not affirmed as made under a 10b5-1 trading plan. It is reported simply as a grant of RSUs under anti-dilution provisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:47 PM Accepted by SEC EDGAR 08/17/2026 - 04:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sarin Arun

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/14/2026		A		13(1)	A	$0	9,627	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Allyson Retson, Attorney-in-Fact for Arun Sarin	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)